No Data
No Data
BioNTech SE: Navigating Short-Term Volatility With Promising Oncology Advancements
BioNTech SE (NASDAQ:BNTX) Analysts Are More Bearish Than They Used To Be
Express News | BioNTech : Deutsche Bank Cuts Target Price to $140 From $150
Citi Initiates BioNTech(BNTX.US) With Buy Rating, Announces Target Price $145
BioNTech Analyst Ratings
Citigroup Initiates BioNTech at Buy With $145 Price Target